Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Synopsis: Marijuana (cannabis) has been studied in relation to the dopamine system, primarily because its main psychoactive component, delta-9-tetrahydrocannabinol (THC), interacts with the brain's endocannabinoid system. The endocannabinoid system modulates various neurotransmitters, including dopamine, which is involved in reward, motivation, and movement. Research shows that acute marijuana use can cause a transient increase in dopamine release, particularly in the striatum, a brain region associated with reward processing. However, chronic or long-term use appears to blunt the brain's dopamine response, potentially leading to reduced motivation and reward sensitivity ("amotivational syndrome") in some users (Volkow et al., 2014). There is limited scientific validation for using marijuana specifically to "support" the dopamine system in a therapeutic context. While some traditional and anecdotal claims exist regarding cannabis’s effects on mood and motivation, high-quality clinical trials demonstrating consistent, beneficial dopamine-related outcomes are lacking. Instead, much of the current evidence points towards potential negative effects with chronic use, such as decreased dopamine synthesis and release. Therefore, while marijuana does interact with the dopamine system, the evidence to support its therapeutic use for this purpose is weak and not widely endorsed by the scientific community.

More about Marijuana
More about Dopamine

Other ingredients that support Dopamine

Other body systems supported by Marijuana

Products containing Marijuana